1
|
Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, Cappuzzo F, Hilgers W, Romano G, Denis F, Viteri S, Debieuvre D, Galetta D, Baldini E, Razaq M, Robinet G, Maio M, Delmonte A, Roch B, Masson P, Schuette W, Zer A, Remon J, Costantini D, Vasseur B, Dziadziuszko R, Giaccone G. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1. Ann Oncol 2023; 34:920-933. [PMID: 37704166 DOI: 10.1016/j.annonc.2023.07.006] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Revised: 07/04/2023] [Accepted: 07/05/2023] [Indexed: 09/15/2023] Open
Abstract
BACKGROUND Patients with advanced non-small-cell lung cancer (NSCLC) treated with immune checkpoint blockers (ICBs) ultimately progress either rapidly (primary resistance) or after durable benefit (secondary resistance). The cancer vaccine OSE2101 may invigorate antitumor-specific immune responses after ICB failure. The objective of ATALANTE-1 was to evaluate its efficacy and safety in these patients. PATIENTS AND METHODS ATALANTE-1 was a two-step open-label study to evaluate the efficacy and safety of OSE2101 compared to standard-of-care (SoC) chemotherapy (CT). Patients with human leukocyte antigen (HLA)-A2-positive advanced NSCLC without actionable alterations, failing sequential or concurrent CT and ICB were randomized (2 : 1) to OSE2101 or SoC (docetaxel or pemetrexed). Primary endpoint was overall survival (OS). Interim OS futility analysis was planned as per Fleming design. In April 2020 at the time of interim analysis, a decision was taken to prematurely stop the accrual due to coronavirus disease 2019 (COVID-19). Final analysis was carried out in all patients and in the subgroup of patients with ICB secondary resistance defined as failure after ICB monotherapy second line ≥12 weeks. RESULTS Two hundred and nineteen patients were randomized (139 OSE2101, 80 SoC); 118 had secondary resistance to sequential ICB. Overall, median OS non-significantly favored OSE2101 over SoC {hazard ratio (HR) [95% confidence interval (CI)] 0.86 [0.62-1.19], P = 0.36}. In the secondary resistance subgroup, OSE2101 significantly improved median OS versus SoC [11.1 versus 7.5 months; HR (95% CI) 0.59 (0.38-0.91), P = 0.017], and significantly improved post-progression survival (HR 0.46, P = 0.004), time to Eastern Cooperative Oncology Group (ECOG) performance status deterioration (HR 0.43, P = 0.006) and Quality of Life Questionnaire Core 30 (QLQ-C30) global health status compared to SoC (P = 0.045). Six-month disease control rates and progression-free survival were similar between groups. Grade ≥3 adverse effects occurred in 11.4% of patients with OSE2101 and 35.1% in SoC (P = 0.002). CONCLUSIONS In HLA-A2-positive patients with advanced NSCLC and secondary resistance to immunotherapy, OSE2101 increased survival with better safety compared to CT. Further evaluation in this population is warranted.
Collapse
Affiliation(s)
- B Besse
- Paris-Saclay University, Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France.
| | - E Felip
- Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona
| | - R Garcia Campelo
- Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, Biomedical Research Institute, INIBIC, A Coruña
| | - M Cobo
- Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain
| | - C Mascaux
- Pneumology Department, Hôpitaux Universitaires de Strasbourg-Nouvel Hôpital Civil, Strasbourg
| | - A Madroszyk
- Medical Oncology Department, IPC-Institut Paoli-Calmettes, Marseille, France
| | - F Cappuzzo
- Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - W Hilgers
- Medical Oncology Department, Sainte Catherine Cancer Center, Avignon, France
| | - G Romano
- Medical Oncology Department, Ospedale Vito Fazzi-ASL Lecce, Lecce, Italy
| | - F Denis
- Medical Oncology Department, Institut Inter-Régional de Cancérologie Jean Bernard-Elsan, Le Mans, France
| | - S Viteri
- Medical Oncology Department, Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Grupo Quironsalud, Barcelona, Spain
| | - D Debieuvre
- Pneumology Department, Groupe Hospitalier de la Région Mulhouse Sud Alsace, Mulhouse, France
| | - D Galetta
- Medical Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari
| | - E Baldini
- Oncology Department, Ospedale San Luca, Lucca, Italy
| | - M Razaq
- Oncology Department, Stephenson Cancer Center, Oklahoma City, USA
| | - G Robinet
- Oncology Department, Centre Hospitalier Régional Universitaire Morvan, Brest, France
| | - M Maio
- Department of Oncology, University of Siena and Center for Immuno-Oncology, University Hospital, Siena
| | - A Delmonte
- Thoracic Department, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Meldola, Italy
| | - B Roch
- Thoracic Oncology Unit, Montpellier University, University Hospital of Montpellier, Montpellier
| | - P Masson
- Pneumology Department, Centre Hospitalier de Cholet, Cholet, France
| | - W Schuette
- Medical Oncology Department, Hospital Martha-Maria Halle-Doelau, Halle, Germany
| | - A Zer
- Thoracic Cancer Service, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
| | - J Remon
- Paris-Saclay University, Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France
| | - D Costantini
- Medical Development Department, OSE Immunotherapeutics, Paris, France
| | - B Vasseur
- Medical Development Department, OSE Immunotherapeutics, Paris, France
| | - R Dziadziuszko
- Oncology and Radiotherapy Department and Early Phase Clinical Trials Centre, Medical University of Gdansk, Gdansk, Poland
| | - G Giaccone
- Meyer Cancer Center, Weill Cornell Medicine, New York, USA
| |
Collapse
|
2
|
Razaq M, Pareek V, Srivastava A, Ramesh R. P2.01-83 Role of Exosomal MicroRNAs (miRNAs) as Predictors of Response to Treatment and Prognosis in Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
3
|
Ho A, Chau N, Bauman J, Bible K, Chintakuntlawar A, Cabanillas M, Wong D, Braña Garcia I, Brose M, Boni V, Even C, Razaq M, Mishra V, Bracken K, Wages D, Scholz C, Gualberto A. Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy287.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
4
|
Rehman HM, Mahmood R, Razaq M, Saeed R, Jamil M, Reddy GVP. Varietal Preferences and Within-Orchard and Tree Distribution of Newly Recorded Gall Midges, Dasineura amaramanjarae and Procontarinia mangiferae (Diptera: Cecidomyiidae), From Commercial Mango Cultivars in Pakistan. Environ Entomol 2017; 46:826-830. [PMID: 28531303 DOI: 10.1093/ee/nvx095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2016] [Indexed: 06/07/2023]
Abstract
Gall midges (Diptera: Cecidomyiidae) damage mango by feeding on flowers and fruit tissues, inducing galls on leaves, and providing inoculums of anthracnose. Dasineura amaramanjarae Grover and Procontarinia mangiferae (Felt), two gall midges that damage flowers in all mango-growing areas of the world, have recently been recorded in Pakistan, and studies were conducted in 2011 and 2012 on the within-tree and orchard distribution patterns and cultivar preference of both species in Pakistan at one location (Rahim Yar Khan). Both gall midge species were found on all mango cultivars examined (Chaunsa, Fajri, Dusehri, Surkha, Sindhri, and Anwar Ratul), with the most damage occurring to Surkha and Dusehri. Research on midge distribution patterns in different parts of mango orchards (central, southern, northern, eastern, and western sides) showed these species to be found in all areas, with the greatest numbers in the central and southern regions. In addition, both species were most abundant on the lower parts of the mango tree canopy.
Collapse
Affiliation(s)
- H M Rehman
- Department of Entomology, University College of Agriculture and Environmental Sciences, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
- CABI Central and West Asia, Opposite 1-A, Data Gunj Bukhsh Rd., Satellite Town, Rawalpindi, Pakistan
| | - R Mahmood
- CABI Central and West Asia, Opposite 1-A, Data Gunj Bukhsh Rd., Satellite Town, Rawalpindi, Pakistan
| | - M Razaq
- Department of Entomology, Faculty of Agriculture Sciences and Technology, Bahauddin Zakariya University, Multan, Pakistan
| | - R Saeed
- Entomology Section, Central Cotton Research Institute, Multan, Punjab, Pakistan
| | - M Jamil
- Department of Soil Science, University College of Agriculture and Environmental Sciences, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
| | - G V P Reddy
- Department of Research Centers, Western Triangle Agricultural Research Center, Montana State University, P. O. Box 656, Conrad, MT 59425
| |
Collapse
|
5
|
Abbas N, Mansoor MM, Shad SA, Pathan AK, Waheed A, Ejaz M, Razaq M, Zulfiqar MA. Fitness cost and realized heritability of resistance to spinosad in Chrysoperla carnea (Neuroptera: Chrysopidae). Bull Entomol Res 2014; 104:707-715. [PMID: 25033090 DOI: 10.1017/s0007485314000522] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
The common green lacewing Chrysoperla carnea is a key biological control agent employed in integrated pest management (IPM) programs for managing various insect pests. Spinosad is used for the management of pests in ornamental plants, fruit trees, vegetable and field crops all over the world, including Pakistan. A field-collected population of C. carnea was selected with spinosad and fitness costs and realized heritability were investigated. After selection for five generations, C. carnea developed 12.65- and 73.37-fold resistance to spinosad compared to the field and UNSEL populations. The resistant population had a relative fitness of 1.47, with substantially higher emergence rate of healthy adults, fecundity and hatchability and shorter larval duration, pupal duration, and development time as compared to a susceptible laboratory population. Mean relative growth rate of larvae, intrinsic rate of natural population increase and biotic potential was higher for the spinosad-selected population compared to the susceptible laboratory population. Chrysoperla species are known to show resistance to insecticides which makes the predator compatible with most IPM systems. The realized heritability (h 2) value of spinosad resistance was 0.37 in spinosad-selected population of C. carnea.
Collapse
Affiliation(s)
- N Abbas
- Department of Entomology, Faculty of Agricultural Sciences and Technology,Bahauddin Zakariya University, Multan,Pakistan
| | - M M Mansoor
- Department of Entomology, Faculty of Agricultural Sciences and Technology,Bahauddin Zakariya University, Multan,Pakistan
| | - S A Shad
- Department of Entomology, Faculty of Agricultural Sciences and Technology,Bahauddin Zakariya University, Multan,Pakistan
| | - A K Pathan
- Arid Zone Research Institute (PARC),UmerKot,Pakistan
| | - A Waheed
- Faculty of Veterinary Sciences,Bahauddin Zakariya University, Multan,Pakistan
| | - M Ejaz
- Department of Entomology, Faculty of Agricultural Sciences and Technology,Bahauddin Zakariya University, Multan,Pakistan
| | - M Razaq
- Department of Entomology, Faculty of Agricultural Sciences and Technology,Bahauddin Zakariya University, Multan,Pakistan
| | - M A Zulfiqar
- Arid Zone Research Institute (PARC),Multan,Pakistan
| |
Collapse
|
6
|
Razaq M, Patsiornik Y, Hussain Z, Ohri A. 4 IMPACT OF HEPATITIS C VIRUS INFECTION ON INCIDENCE OF ERYTHROCYTE AUTOANTIBODIES IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION.:. J Investig Med 2006. [DOI: 10.2310/6650.2005.x0015.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
7
|
Razaq M, Patsiornik Y, Hussain Z, Ohri A. Impact of Hepatitis c Virus Infection on Incidence of Erythrocyte Autoantibodies in Patients with Human Immunodeficiency Virus Infection. J Investig Med 2006. [DOI: 10.1177/108155890605402s04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- M. Razaq
- Division of Hematology, Coney Island Hospital, Brooklyn, NY
- Department of Medicine, Coney Island Hospital, Brooklyn, NY
| | - Y. Patsiornik
- Department of Medicine, Coney Island Hospital, Brooklyn, NY
| | - Z. Hussain
- Department of Medicine, Coney Island Hospital, Brooklyn, NY
| | - A. Ohri
- Division of Hematology, Coney Island Hospital, Brooklyn, NY
- Department of Medicine, Coney Island Hospital, Brooklyn, NY
| |
Collapse
|
8
|
Mankan N, Razaq M, Fernandez G, Hussain S. A case of concomitant malignant gastro-intestinal stromal tumour and high grade myelodysplastic syndrome. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.9051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
9
|
Mankan N, Joseph M, Razaq M, Kanagarajan K, Maini A. 296 TO EVALUATE THE EFFECT OF ANGIOTENSIN-CONVERTING INHIBITORS ON HEMATOCRIT IN MODERATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE:. J Investig Med 2005. [DOI: 10.2310/6650.2005.00006.295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
10
|
Razaq M, Mankan N, Puskur B, Mahajan N, Hussain S. 134 SENSITIVITY OF ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR LUPUS ANTICOAGULANT DONE BY ACTIN FSL (DADE) AND THROMBOSIL (HEMOLIANCE). J Investig Med 2005. [DOI: 10.2310/6650.2005.00006.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
11
|
Razaq M, Mankan N, Hussain S. 51 INCIDENCE OF TRUE B12 DEFICIENCY IN FEMALES WITH “LOW NORMAL” SERUM B12. J Investig Med 2004. [DOI: 10.1136/jim-52-suppl2-51] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
12
|
Chu D, Gervasio D, Razaq M, Yeager EB. Infrared reflectance absorption spectroscopy (IRRAS). Study of the thermal stability of perfluorinated sulphonic acid ionomers on Pt. J APPL ELECTROCHEM 1990. [DOI: 10.1007/bf01012486] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
13
|
|
14
|
|
15
|
Pletcher D, Razaq M, Smilgin GD. High current density organic electrosynthesis via metal powders in multiphase systems. J APPL ELECTROCHEM 1981. [DOI: 10.1007/bf00616680] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
16
|
Hohammad M, Razaq M. Stopped-flow voltammetry. J Electroanal Chem (Lausanne) 1979. [DOI: 10.1016/s0022-0728(79)80272-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
17
|
|